Ignite Creation Date:
2024-05-05 @ 11:36 PM
Last Modification Date:
2024-10-26 @ 10:36 AM
Study NCT ID:
NCT01364077
Status:
UNKNOWN
Last Update Posted:
2012-06-21
First Post:
2011-05-25
Brief Title:
Ivabradine in Hemodialysed Patients With Increased Heart Rate
Sponsor:
University of Campania Luigi Vanvitelli
Organization:
University of Campania Luigi Vanvitelli
Study Overview
Official Title:
Efficacy and Safety of Ivabradine in Hemodialysed Patients With Increased Heart Rate
Status:
UNKNOWN
Status Verified Date:
2012-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A significant association between resting heart rate HR and both all-cause mortality and cardiovascular mortality has been demonstrated in numerous epidemiologic studies for both the general population and for patients with cardiovascular disease
Cardiac disease is the leading cause of death among hemodialysis HD patients a recent study reported that the 48-hr mean HR is an independent predictor of cardiovascular events in normotensive hemodialysis patients
Ivabradine a pure HR lowering agentacting on If current inhibition has proven beneficial antianginal effects and mortality reduction linked to HR reduction in ischemic patients
Aim
To evaluate the safety and efficacy of ivabradine in normotensive hemodialysed patients with increased pre-dialysis HR 80 bpm
Cardiac disease is the leading cause of death among hemodialysis HD patients a recent study reported that the 48-hr mean HR is an independent predictor of cardiovascular events in normotensive hemodialysis patients
Ivabradine a pure HR lowering agentacting on If current inhibition has proven beneficial antianginal effects and mortality reduction linked to HR reduction in ischemic patients
Aim
To evaluate the safety and efficacy of ivabradine in normotensive hemodialysed patients with increased pre-dialysis HR 80 bpm
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| IV-DIAL01-A | OTHER | Second Univesity of Naples | None |